Publications by authors named "Surai Jones"

Claim this Profile
F
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.
Peter Schmid, Nicholas C Turner, Carlos H Barrios, Steven J Isakoff, Sung-Bae Kim, Surai Jones

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation-Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study.
Paolo A Ascierto, Brigitte Dréno, James Larkin, Antoni Ribas, Gabriella Liszkay, Surai Jones

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with -Mutant Cancers.
Komal Jhaveri, Matthew T Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Surai Jones

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS).
Franck Morschhauser, Ian W Flinn, Ranjana Advani, Laurie H Sehn, Catherine Diefenbach, Surai Jones

Lancet Haematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
Ranjana H Advani, Daniel Lebovic, Andy Chen, Mark Brunvand, Andre Goy, Surai Jones

Clin Cancer Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Maria Corinna A Palanca-Wessels, Myron Czuczman, Gilles Salles, Sarit Assouline, Laurie H Sehn, Surai Jones, Cheryl Jones

Lancet Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receipt of cervical cancer screening in female veterans: impact of posttraumatic stress disorder and depression.
Julie C Weitlauf, Surai Jones, Xiangyan Xu, John W Finney, Rudolf H Moos

Womens Health Issues· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation.
Judith Chapman, Megan Oser, Jill Hockemeyer, Julie Weitlauf, Surai Jones

Am J Gastroenterol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual violence, posttraumatic stress disorder, and the pelvic examination: how do beliefs about the safety, necessity, and utility of the examination influence patient experiences?
Julie C Weitlauf, Susan M Frayne, John W Finney, Rudolf H Moos, Surai Jones

J Womens Health (Larchmt)· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distress and pain during pelvic examinations: effect of sexual violence.
Julie C Weitlauf, John W Finney, Josef I Ruzek, Tina T Lee, Ann Thrailkill, Surai Jones

Obstet Gynecol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis